// App-Quantinova.ai

10020 : Vitamin D and aromatase inhibitor-induced arthralgia: Analysis of Canadian cancer trial group MA.27 data.

Researchers

Presenter

  • Polly Ann Niravath

Principal Investigators

  • Bingshu E. Chen

  • Judy Anne Chapman

  • Sandeep K Agarwal

  • Robert L Welschhans

  • Tim Bongartz

  • Krishna R. Kalari

  • Lois E. Shepherd

  • John Bartlett

  • Kathleen I. Pritchard

  • Karen A. Gelmon

  • Susan G. Hilsenbeck

  • Mothaffar F. Rimawi

  • C. Kent Osborne

  • Paul E. Goss

  • James N. Ingle

Medical Centers

  • Baylor College of Medicine, Houston, TX

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

  • Mayo Clinic, Rochester, MN

  • Canadian Cancer Trials Group, Kingston, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Smith Breast Center At BCM, Houston, TX

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Inflammatory Arthritis

  • Solid malignancies

Biomarkers

  • Interleukin 10

  • Interleukin 17A

  • Interleukin 6

  • Interleukin-23

  • Tumor necrosis factor

  • Body mass index

Drug/Treatment

  • Ergocalciferol

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved